VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
AstraZeneca PLC vs InterContinental Hotels Group PLC
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisInterContinental Hotels Group PLC
IHG · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into InterContinental Hotels Group PLC's moat claims, evidence, and risks.
View IHG analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 57 / 100 for InterContinental Hotels Group PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); InterContinental Hotels Group PLC has 5 segments (36% in Fee business (franchise, management and ancillary fees)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; InterContinental Hotels Group PLC has 8 across 3.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
InterContinental Hotels Group PLC
Fee business (franchise, management and ancillary fees)
Branded hotel franchising and management services
Global
Hotel owners and developers
Franchisor and hotel manager (asset-light brand platform)
36%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
InterContinental Hotels Group PLC strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
InterContinental Hotels Group PLC segments
Full profile >Fee business (franchise, management and ancillary fees)
Oligopoly
System Fund (marketing, reservations and loyalty assessments)
Monopoly
Reimbursable revenues (managed hotel staff reimbursements)
Competitive
Owned, leased and managed lease hotels
Competitive
Insurance activities (ancillary)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.